Abstract:Abstract A 52-year-old man with a history of common variable immunodeficiency (CVID) secondary to NFKB1 haploinsufficiency was referred to the dermatology clinic. He had a worsening rash on his arms and legs with a background of a longstanding rash on his trunk for the last 2 years and his groin area for the preceding 12 years. He was diagnosed with CVID in 2009 and was receiving three-weekly intravenous immunoglobulin infusions. He had a history of childhood eczema and his son also had a history of eczema. On examination, the patient had erythematous infiltrated impetiginized plaques on his upper abdomen, buttocks and thighs and more subtle patches on his right chest consistent with a diagnosis of mycosis fungoides. His modified Severity-Weighted Assessment Score was 27.6 (patch 3.4%, plaque 12.1%). His staging investigations identified a weak clonal T-cell population in his bone marrow biopsy [B0b (L) lymphopenia]; a fludeoxyglucose F18 (FDG) avid lymph node in the region of his rash (likely dermatographic) and a discordant B-cell lymphoproliferation in biopsies of his FDG avid lung lesions. Lymphoma occurs in an estimated 2–8% of patients with CVID, the majority of which are non-Hodgkin lymphoma. To our knowledge, this is the first reported case of mycosis fungoides, the most common form of cutaneous T-cell lymphoma (CTCL) arising in a patient with NFKB1 haploinsufficiency. A recent report by Spangenberg et al. (Spangenberg MN, Grille S, Simoes C et al. Case report: mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation. Front Oncol 2023; 13: 1248964) described a family with two brothers who presented with mycosis fungoides as an exclusive symptom of a CVID, where whole-exome sequencing of the index patient revealed a pathogenic variant of the NFKB2 gene. High constitutive nuclear factor (NF)-κB activity in CTCL is responsible for increased malignant cell survival and proliferation and induction of NF-κB-dependent proinflammatory and anti-inflammatory cytokines. The role of NF-κB in CTCL lymphomagenesis warrants further investigation. Our case highlights that not only does a gain in NF-κB activity appear to confer an increased risk of developing mycosis fungoides, but a loss of such activity can also appear to confer an increased risk.

Cns Involvement From Mycosis Fungoides With CD 30 Transformation

Primary Melanocytoma of Central Nervous System:A Clinicopathologic Analysis of Two Cases

A Case of Primary Cutaneous CD30~+ Anaplastic Large Cell Lymphoma with Central Nerve System Involvement

Ichthyosiform Mycosis Fungoides with Alopecia and Atypical Membranous Nephropathy

Mycosis Fungoides: A Multidisciplinary Team Approach.

A Man with Worsening Scaling Plaques and a New Onset Large Draining Ulcerated Tumor

Systemic involvement in mycosis fungoides

Acquisition of TP63 Rearrangement in Large Cell Transformation of Mycosis Fungoides

Photosensitive presentation of aggressive mycosis fungoides mimicking systemic lupus erythematosus

Folliculotropic Mycosis Fungoides

Transcriptomic changes during stage progression of mycosis fungoides

Unveiling the Rarity: CD20 Expression in Mycosis Fungoides and Its Clinical Significance

When mycosis fungoides seems not to be within the spectrum of clinical and histopathological differential diagnoses

Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma

Nimg-86. Disseminatedcryptococcus Neoformans Mimicking Central Nervous System Progression Of Diffuse Large B-Cell Lymphoma

BI29 Mycosis fungoides presenting in a patient with NFKB1 haploinsufficiency-associated common variable immunodeficiency

Mycosis fungoides stage IB progressing to cutaneous tumors

A Comprehensive Study on Aberrant CD20-Positive Mycosis Fungoides: Clinical and Prognostic Insights

Null T‐cell phenotype mycosis fungoides with aberrant CD20 and CD56 expression: A diagnostic dilemma

Path-43. Malignant Transformation Of Meningeal Melanocytoma - Genetic Alterations And Response To Checkpoint Blockade Immunotherapy

Inflammatory myofibroblastic tumor with CNS involvement